Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo

Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression

(2012) KEMING YU et al.   ONCOLOGY REPORTS

Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo

(2011) Xiaofei Lei et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury

(2011) Lihong Fan et al.   JOURNAL OF VASCULAR SURGERY

Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein

(2011) Yinxu Zhang et al.   MEDICAL ONCOLOGY

Synergistic Antitumor Effect of the Activated PPAR  and Retinoid Receptors on Human Osteosarcoma

(2010) B. C. He et al.   CLINICAL CANCER RESEARCH

Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor

(2009) Lei Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Multidisciplinary Management of Osteosarcoma

(2009) Noah Federman et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Osteosarcoma Development and Stem Cell Differentiation

(2008) Ni Tang et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: Potential therapeutic application for treatment of gliomas

(2008) Yu-Show Fu et al.   NEURO-ONCOLOGY